[Direct breaks in a single-stranded DNA fragment by a bleomycin-derived oligonucleotide]

Area of Science:

• Biochemistry
• Molecular Biology
• Medicinal Chemistry

Background:

• Bleomycin is a potent DNA-cleaving agent used in cancer therapy.
• Oligonucleotides can be designed for specific DNA targeting.
• Conjugating therapeutic agents to targeting molecules can improve efficacy and reduce side effects.

Purpose of the Study:

• To develop a method for covalently linking bleomycin to an oligonucleotide.
• To evaluate the DNA-cleaving activity and stability of the resulting conjugate.
• To compare the cleavage activity of the conjugate with free bleomycin.

Main Methods:

• Coupling of bleomycin A5 Cu(II)-complex (Cu(II)Blm-RH) to the 5'-phosphate group of oligonucleotide pd(CCAAACA) using triphenylphosphine and 2,2'-dipyridyldisulphide.
• Activation of the oligonucleotide's phosphate group.
• Removal of the Cu(II) ion from the conjugate.
• Assessment of DNA cleavage activity using a target oligonucleotide pd(TGTTTGGCGAAGGA).
• Determination of complex stability by measuring melting temperature changes (ΔTm).

Main Results:

• A bleomycin-oligonucleotide conjugate (Ia) was synthesized with a 70% yield.
• The conjugate (Ia) formed more stable complementary complexes than the parent oligonucleotide (ΔTm = 11 °C).
• The de-copperted conjugate (Ib) effectively cleaved the target oligonucleotide pd(TGTTTGGCGAAGGA) with 80% efficiency.
• Neither the control oligonucleotide nor the oligonucleotide tail of the reagent were degraded during cleavage.
• Bleomycin bound to the reagent (Ib) and free bleomycin damaged different regions of the target DNA.

Conclusions:

• A novel method for conjugating bleomycin to oligonucleotides was successfully established.
• The resulting bleomycin-oligonucleotide conjugate exhibits enhanced complex stability and potent, targeted DNA cleavage activity.
• This approach holds promise for developing more specific and effective DNA-damaging agents for therapeutic applications.